Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/913
Name: Drug, bio-affecting and body treating compositions > Ophthalmic > Glaucoma
Description: Subject matter wherein the ophthalmic disorder is glaucoma.










Patents under this class:
1 2 3 4 5 6 7 8 9 10

Patent Number Title Of Patent Date Issued
5308849 Method of reducing elevated intraocular pressure May. 3, 1994
5306731 Method and products for treating the eye Apr. 26, 1994
5304569 Compositions and their use in lowering intraocular pressure Apr. 19, 1994
5304561 New concept in glaucoma treatment Apr. 19, 1994
5304559 Compositions containing a 4-quinolone derivative complexed with a divalent metal ion Apr. 19, 1994
5300296 Antimicrobial agent for opthalmic formulations Apr. 5, 1994
5292754 Treatment for hypertension or glaucoma in eyes Mar. 8, 1994
5290781 Ketaneserinol as an agent to reduce intraocular pressure Mar. 1, 1994
5283262 Phenethanolamine derivatives Feb. 1, 1994
5281591 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure Jan. 25, 1994
5275820 Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles Jan. 4, 1994
5273976 Ocular hypotensive agents Dec. 28, 1993
5273742 Biomedical water soluble hydrophilic polyurethane polymers and method of use thereof Dec. 28, 1993
5272176 Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use Dec. 21, 1993
RE34440 Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions Nov. 9, 1993
5260059 Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor Nov. 9, 1993
5256658 Angiotensin II inhibitors Oct. 26, 1993
5256408 Aminosteroids for ophthalmic use Oct. 26, 1993
5254593 Compositions containing biguanides and derivatives thereof as inhibitors of nonenzymatic cross-linking Oct. 19, 1993
5252583 Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension Oct. 12, 1993
5252318 Reversible gelation compositions and methods of use Oct. 12, 1993
5252319 Aminosteroids for ophthalmic use Oct. 12, 1993
5252595 Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-t Oct. 12, 1993
5252607 Treatment of low pressure glaucoma and ischemic retinal degeneration Oct. 12, 1993
5238961 PGF 1-alcohols and their use as ocular hypotensives Aug. 24, 1993
5236951 Pharmaceutical compositions for the treatment of ocular disorders Aug. 17, 1993
5234634 Method for preparing alpha-tocopherol vesicles Aug. 10, 1993
5229127 Rapid miosis with control of intraocular pressure using a mixture of a cetylcholine and carbachol derivatives Jul. 20, 1993
5227404 Pharmaceutical composition for the treatment of glaucomatous optic neuropathy Jul. 13, 1993
5219851 Tetrahydroisoquinoline-type renin inhibiting peptides Jun. 15, 1993
5219849 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma Jun. 15, 1993
5215991 Combination of selective alpha-adrenergic agonists and Na.sup.+ /H.sup.+ e x Jun. 1, 1993
5212162 Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions May. 18, 1993
5212196 Control of post-surgical intraocular pressure using clonidine derivatives May. 18, 1993
5212168 Method of and solution for treating glaucoma May. 18, 1993
5209926 Aminosteroids for ophthalmic use May. 11, 1993
5208256 Treatment of ocular hypertension with a synergistic combination for ocular administration May. 4, 1993
5202347 Soft .beta.-adrenergic blocking agents Apr. 13, 1993
5200180 Pharmaceutical composition for the treatment of the human eye Apr. 6, 1993
5200453 Preservative for ophthalmic solutions Apr. 6, 1993
5194429 Ocular hypotensive agents Mar. 16, 1993
5194449 Use of prostaglandin F.sub.3.alpha. as an ocular hypotensive agent Mar. 16, 1993
5192535 Ophthalmic suspensions Mar. 9, 1993
5188826 Topical ophthalmic suspensions Feb. 23, 1993
5182102 Anti-glaucoma compositions Jan. 26, 1993
5180721 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure Jan. 19, 1993
5177105 Methods for controlling intraocular pressure with transition metal complexes Jan. 5, 1993
5175189 Treatment of ocular hypertension with a synergistic combination for ophthalmic use Dec. 29, 1992
5175161 Occular hypotensive agents Dec. 29, 1992
5173507 Prostaglandin combinations in glaucoma therapy Dec. 22, 1992

1 2 3 4 5 6 7 8 9 10










 
 
  Recently Added Patents
Methods and systems for motion estimation with nonlinear motion-field smoothing
Method of forming solderable side-surface terminals of quad no-lead frame (QFN) integrated circuit packages
Pharmaceutical composition comprising gabapentin or an analogue thereof and an .alpha.-aminoamide and its analgesic use
Method and structure of forming backside through silicon via connections
High pressure refolding of protein aggregates and inclusion bodies
System and method for receiving MBMS broadcasting service
Display apparatus, control method thereof, and program
  Randomly Featured Patents
System for insulating attic openings
Process for manufacturing a top spin valve
Actuator of anti-skid device for motor vehicles
High production laser welding assembly and method
Method and system for digitizing handwriting
Method for driving an actuator, actuator drive, and apparatus comprising an actuator
Gear control system intended in particular for an electrically operated automatic transmission of layshaft design
Refuse container with molded hinge
Compact pulse shaping for QM-MSK and PAM/QAM transmission
Film storage and developing cassette